The undersigned organizations write to express our support for the use of the Congressional Review Act (CRA) to overturn the Federal Trade Commission's (FTC) recent premerger notification rules ("Rules").
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
The Honorable Chuck GrassleyUnited States Senate135 Hart Senate Office BuildingWashington, DC 20510The Honorable Peter WelchUnited States Senate
The AHA asks President Trump to consider granting exceptions to the current and proposed tariffs for medical devices and pharmaceuticals made in Mexico, Canada and China that are essential to the provision of safe, effective care in America's hospitals, clinics, and other settings.
AHA comments on draft Medicare graduate medical education (GME) reform package (KEL24743 MP2).
January 27, 2025Jeff WuActing AdministratorCenters for Medicare & Medicaid Services7500 Security BlvdBaltimore, MD 21244
A follow-up to Baxter’s communication on December 13, 2024 regarding increases in allocations for several U.S. IV products,
AHA Comments in advance of MedPAC January 2025 meeting.
AHA shares feedback in response to the Centers for Medicare & Medicaid Services’ information collection request (ICR) regarding the Medicare Transaction Facilitator (MTF) and the Medicare drug negotiation program.
AHA comments regarding the Centers for Medicare & Medicaid Services Medicare $2 Drug List (M2DL) Model request for information (RFI).
AHA comments regarding the Medicare Payment Advisory Commission (MedPAC) November meeting sessions related to physician fee schedule payments, advanced alternative payment model (A-APM) incentives and Medicare Advantage (MA) network adequacy.